AstraZeneca
NEWS
GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
Taking Seroquel with methadone can be fatal. Did the drugmaker’s warnings fall short?
The move is welcome news for Prime Minister Theresa May, who has struggled to win over large sections of industry as Britain prepares to leave the European Union.
Genentech’s Hemlibra just got approved but is expected to bring in around $2 billion in peak sales.
China revenue in Q3 increased by 12 percent at AstraZeneca and the country now accounts for 15 percent of its global product sales.
The companies will advance the new Relaxin development candidate, AZD7970, toward the clinic as an investigational treatment for heart failure.
Astra and its MedImmune division announced that two Phase III clinical trials of tralokinumab for severe, uncontrolled asthma failed to meet their primary endpoints.
Astra and Incyte are pushing forward on the development of immunotherapy combination treatments.
JOBS
IN THE PRESS